# Rivastigmine

NDC: 0378-9070
Generic name: rivastigmine
Labeler / Manufacturer: Mylan Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: PATCH
Routes: TRANSDERMAL
Marketing started: 20180620

FDA application: ANDA205622

## Active ingredients

- RIVASTIGMINE: 4.6 mg/24h

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0378-9070"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0378-9070
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4ab335d1-19ee-4cd9-9776-8086645d19e4